227 related articles for article (PubMed ID: 11794886)
61. [Effects of estrogen and selective estrogen receptor modulators on osteoporosis].
Urano T
Clin Calcium; 2005 Apr; 15(4):591-5. PubMed ID: 15802770
[TBL] [Abstract][Full Text] [Related]
62. Diagnosing and managing post menopausal osteoporosis: opportunities for fracture prevention.
McGarry KA; Tammaro D; Cyr MG
Compr Ther; 2003; 29(2-3):115-23. PubMed ID: 14606341
[TBL] [Abstract][Full Text] [Related]
63. Raloxifene therapy in the reduction of fractures.
Cefalu CA
Am Fam Physician; 2000 Mar; 61(5):1272, 1275, 1279-80. PubMed ID: 10735336
[No Abstract] [Full Text] [Related]
64. [Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front].
MMW Fortschr Med; 2003 Jul; 145(27-28):63. PubMed ID: 14587198
[No Abstract] [Full Text] [Related]
65. Treating osteoporosis in post-menopausal women: a case approach.
Keller MI
Cleve Clin J Med; 2004 Oct; 71(10):829-37. PubMed ID: 15529489
[TBL] [Abstract][Full Text] [Related]
66. ACOG practice bulletin. Selective estrogen receptor modulators. Number 39, October 2002 (replaces Committee Opinion Number 224, October 1999).
American College of Obsterticians and Gynecologists Committee on Practice Bulletins-Gynecology
Int J Gynaecol Obstet; 2002 Dec; 79(3):289-98. PubMed ID: 12501867
[TBL] [Abstract][Full Text] [Related]
67. Benefit-risk assessment of raloxifene in postmenopausal osteoporosis.
Cranney A; Adachi JD
Drug Saf; 2005; 28(8):721-30. PubMed ID: 16048357
[TBL] [Abstract][Full Text] [Related]
68. Raloxifene reduces vertebral fracture risk in postmenopausal women with osteoporosis.
Brandi ML
Clin Exp Rheumatol; 2000; 18(3):309-10. PubMed ID: 10895366
[No Abstract] [Full Text] [Related]
69. [Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases].
Higuchi T; Mizunuma H
Clin Calcium; 2004 Oct; 14(10):81-4. PubMed ID: 15577136
[TBL] [Abstract][Full Text] [Related]
70. Prevention and treatment of osteoporosis.
Lloyd M
Clin Med (Lond); 2001; 1(2):155-6. PubMed ID: 11333463
[No Abstract] [Full Text] [Related]
71. Update in general internal medicine.
Mincey BA
Ann Intern Med; 2001 Aug; 135(4):300-1. PubMed ID: 11511149
[No Abstract] [Full Text] [Related]
72. Selective estrogen receptor modulators and prevention of invasive breast cancer.
Gradishar WJ; Cella D
JAMA; 2006 Jun; 295(23):2784-6. PubMed ID: 16754726
[No Abstract] [Full Text] [Related]
73. [The role of raloxifene (Evista) in the treatment and prevention of postmenopausal osteoporosis].
Korsić M
Reumatizam; 2003; 50(2):55-7. PubMed ID: 15098379
[TBL] [Abstract][Full Text] [Related]
74. Tolerability profile of SERMs.
Agnusdei D; Iori N
J Endocrinol Invest; 1999 Sep; 22(8):641-5. PubMed ID: 10532252
[No Abstract] [Full Text] [Related]
75. The gynecologic effects of lasofoxifene, an estrogen agonist/antagonist, in postmenopausal women.
Archer DF
Menopause; 2011 Jan; 18(1):6-7. PubMed ID: 21173718
[No Abstract] [Full Text] [Related]
76. Latest innovation in the treatment of osteoporosis: SERMs and the role of parathyroid hormone.
Thiebaud D
J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S124-5. PubMed ID: 21213508
[No Abstract] [Full Text] [Related]
77. Upstaging tamoxifen? New classes of drugs emerging for breast cancer.
Twombly R
J Natl Cancer Inst; 2002 Apr; 94(7):474-5. PubMed ID: 11929942
[No Abstract] [Full Text] [Related]
78. Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden: an economic evaluation based on the MORE study.
Borgström F; Johnell O; Kanis JA; Oden A; Sykes D; Jönsson B
Pharmacoeconomics; 2004; 22(17):1153-65. PubMed ID: 15612833
[TBL] [Abstract][Full Text] [Related]
79. [Prevention of breast cancer 2007. New evidence?].
Marzo Castillejo M
Aten Primaria; 2007 Mar; 39(3):115-7. PubMed ID: 17386201
[No Abstract] [Full Text] [Related]
80. Raloxifene to prevent postmenopausal osteoporosis.
Drug Ther Bull; 1999 May; 37(5):33-6. PubMed ID: 10563056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
